University of Virginia Clinical Trials
Sponsors / University of Virginia
According to ClinicalTrials.gov, University of Virginia has served as lead sponsor on 312 registered trials. Across the portfolio, 44 are in recruitment, 13 are active non-recruiting, and 133 have reached completion. 23 trials have been terminated or withdrawn. The most common reasons cited for termination include slow or insufficient recruitment, funding constraints. Across the portfolio, planned enrollment totals 146,959 participants. Data on this page mirrors the ClinicalTrials.gov registry as of the most recent refresh.
312
Total Trials
44
Recruiting
13
Other Active
133
Completed
23
Terminated / Withdrawn
146,959
Total Enrollment
Termination reasons: Recruitment35% · Other35% · Funding22% · Safety4% · Efficacy4%
Recent Terminations
- Ovarian Cancer"Accrual not meeting pre-specified numbers."
- Colorectal Cancer"Company providing the computer application for exercise intervention suddenly closed for business"
- Adhesive Capsulitis"Not able to find enough subjects"
- Ketogenic Diet"low enrollment"
- Medication Adherence"Study closed due to not able to find any real stroke patients interested to participate."
- Exercise"Personnel and funding issues"
- Septic Shock"No funding for the study; not enough staff"
- Breast Cancer Female"slow study accrual, partially due to pandemic"
- NCT04748302 Stopped Apr 2020Multiple Sclerosis"COVID"
- Fractures, Open"Unable to continue study due to funding and personnel restraints"
Active Trials (13 total)
- NCT04465500
- NCT05660525
- NCT05550896
- NCT06599229
- Pancreas Cancer PHASE1/PHASE2NCT06479239
- Acute Myeloid Leukemia PHASE1NCT07270978
- NCT05653518
- Cardiovascular Health PHASE2NCT07186660
- Breast Cancer Female PHASE3NCT06507618
- NCT05962242
- Bleeding Disorder PHASE1NCT06118372
- Alzheimer Disease PHASE2NCT05063851
- NCT06009276
- Exercise Capacity PHASE4NCT06638671
- NCT06831968
- NCT05370469
- NCT05396911
- NCT06161675
- NCT06600178
- Vaginitis NANCT06070454